BRPI0408827A - composições oftálmicas preservadas - Google Patents

composições oftálmicas preservadas

Info

Publication number
BRPI0408827A
BRPI0408827A BRPI0408827-1A BRPI0408827A BRPI0408827A BR PI0408827 A BRPI0408827 A BR PI0408827A BR PI0408827 A BRPI0408827 A BR PI0408827A BR PI0408827 A BRPI0408827 A BR PI0408827A
Authority
BR
Brazil
Prior art keywords
component
components
ophthalmic compositions
compositions
present
Prior art date
Application number
BRPI0408827-1A
Other languages
English (en)
Inventor
James N Chang
Richard Graham
Orest Olejnik
Stanley W Huth
Michelle Luu
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0408827A publication Critical patent/BRPI0408827A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"COMPOSIçõES OFTáLMICAS PRESERVADAS". A presente invenção refere-se a composições oftálmicas que incluem um componente veículo, um componente de óxi-cloro, presente em uma quantidade efetiva para preservar a composição e pelo menos um componente adicional, por exemplo, um componente de borato e/ou um componente de glicerina, presente em uma quantidade efetiva para melhorar a eficácia de preservação da composição. As composições, preferencialmente, também incluem um ou mais outros componentes, tais como, componentes terapêuticos, por exemplo, componentes de quinoxalina e componentes polianiónicos, efetivos para prover as composições com uma ou mais funcionalidades.
BRPI0408827-1A 2003-03-27 2004-03-23 composições oftálmicas preservadas BRPI0408827A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/400,893 US20040191332A1 (en) 2003-03-27 2003-03-27 Preserved ophthalmic compositions
PCT/US2004/008913 WO2004087098A2 (en) 2003-03-27 2004-03-23 Preserved ophthalmic compositions

Publications (1)

Publication Number Publication Date
BRPI0408827A true BRPI0408827A (pt) 2006-04-04

Family

ID=32989309

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408827-1A BRPI0408827A (pt) 2003-03-27 2004-03-23 composições oftálmicas preservadas

Country Status (9)

Country Link
US (1) US20040191332A1 (pt)
EP (1) EP1605912A2 (pt)
JP (1) JP2006521362A (pt)
CN (1) CN100528139C (pt)
AU (1) AU2004226466B2 (pt)
BR (1) BRPI0408827A (pt)
CA (1) CA2520521C (pt)
NZ (1) NZ542727A (pt)
WO (1) WO2004087098A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US8529927B2 (en) * 2004-04-30 2013-09-10 Allergan, Inc. Alpha-2 agonist polymeric drug delivery systems
US7465412B2 (en) * 2004-10-28 2008-12-16 Ppg Industries Ohio, Inc. Calcium hypochlorite composition
US9452133B2 (en) 2005-04-25 2016-09-27 KEM Patent Holdings, LLC Method for preventing nasolacrimal duct obstruction
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
KR101633449B1 (ko) * 2007-07-26 2016-06-24 아자드 파르마 아게 전기화학적으로 활성화된 치아염소산염 용액을 포함하는 약제학적 제제
US20090220618A1 (en) * 2008-02-29 2009-09-03 Erning Xia Pharmaceutical formulations comprising polyanionic materials and source of hydrogen peroxide
AU2011237677A1 (en) 2010-04-07 2012-11-08 Allergan, Inc. Combinations of preservative compositions for ophthalmic formulations
WO2011127151A2 (en) 2010-04-07 2011-10-13 Allergan, Inc. Combinations of preservatives for ophthalmic compositions
US20140163080A1 (en) * 2011-02-03 2014-06-12 Gnt, Llc Compositions and Methods for Treatment of Glaucoma
EP2630952A1 (en) 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
WO2014074605A1 (en) * 2012-11-08 2014-05-15 Allergan, Inc. Preserved topical formulations with improved antimicrobial activity
US20140378401A1 (en) * 2013-06-21 2014-12-25 Gnt, Llc Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations
TWI673071B (zh) * 2017-01-13 2019-10-01 National Taipei University Of Technology 眼科用組合物
US10293047B1 (en) 2017-11-15 2019-05-21 Paragon BioTeck, Inc. Fluorescein and benoxinate compositions
TWI798498B (zh) * 2019-10-23 2023-04-11 永勝光學股份有限公司 具有高效抗微生物能力與潤滑效果的溶液

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US71874A (en) * 1867-12-10 haskell
US27811A (en) * 1860-04-10 Joseph kbech
US32201A (en) * 1861-04-30 John Neumann Faucet
US198209A (en) * 1877-12-18 Improvement in the manufacture of metallic leaf
US23098A (en) * 1859-03-01 Improvement in horse-rakes
US3278447A (en) * 1963-12-02 1966-10-11 Cloro Bac Products Inc Process for stabilizing chlorine dioxide solution
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US3910296A (en) * 1973-04-20 1975-10-07 Allergan Pharma Method of removing proteinaceous deposits from contact lenses
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4136178A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4474787A (en) * 1977-05-04 1984-10-02 Fisons Limited 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof
ATE6466T1 (de) * 1979-10-26 1984-03-15 Smith And Nephew Associated Companies P.L.C. Autoklavierbare emulsionen.
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4411801A (en) * 1981-09-17 1983-10-25 Nl Industries, Inc. Low solids well servicing fluids
US4525346A (en) * 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4758595A (en) * 1984-12-11 1988-07-19 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
USRE32672E (en) * 1985-09-09 1988-05-24 Allergan, Inc. Method for simultaneously cleaning and disinfecting contact lenses using a mixture of peroxide and proteolytic enzyme
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US5089509A (en) * 1988-09-15 1992-02-18 Allergan, Inc. Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
US4861514A (en) * 1988-06-08 1989-08-29 The Drackett Company Compositions containing chlorine dioxide and their preparation
CA2003198C (en) * 1988-11-29 1995-03-21 Anthony J. Dziabo, Jr. Aqueous ophthalmic solutions and method for preserving same
US5021416A (en) * 1989-10-31 1991-06-04 Allergan, Inc. Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
US5089053A (en) * 1989-11-09 1992-02-18 Polymer Technology Corporation Contact lens cleaning material and method
US5145643A (en) * 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5212162A (en) * 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
EP0656779B1 (en) * 1992-08-28 2000-04-12 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
ATE241389T1 (de) * 1992-12-17 2003-06-15 Advanced Medical Optics Inc Oxidationsmittel und polyvinylpyrrolidon enthaltende desinfektionslösung für kontaktlinsen
US5648074A (en) * 1993-05-25 1997-07-15 Allergan Compositions and methods for disinfecting contact lenses and reducing proteinaceous deposit formation
JP3683908B2 (ja) * 1993-10-13 2005-08-17 アラーガン、インコーポレイテッド (2−イミダゾリン−2−イルアミノ)キノキサリン誘導体の使用方法
JPH07316038A (ja) * 1994-05-23 1995-12-05 Ikeda Mohandou:Kk 粘膜投与用薬剤組成物
US5965160A (en) * 1995-04-24 1999-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6000534A (en) * 1996-08-16 1999-12-14 Allergan Sales, Inc. Contact lens disinfecting device and disinfection system
JP3402613B2 (ja) * 1996-09-26 2003-05-06 ロート製薬株式会社 点眼剤
US5858346A (en) * 1997-05-09 1999-01-12 Allergan Compositions and methods for enhancing contact lens wearability
US5993864A (en) * 1997-07-11 1999-11-30 Kross; Robert D. Chlorine dioxide chelate compositions and method of use
BR9810729B1 (pt) * 1997-07-29 2010-07-13 composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsificante.
NZ502567A (en) * 1997-07-29 2002-03-28 Upjohn Co Self-emulsifying formulation for lipophilic compounds containing a pyranone and a mixture of monoglycerides and diglycerides
US6841684B2 (en) * 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
US5981607A (en) * 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
JP2002523475A (ja) * 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
WO2000019981A1 (en) * 1998-10-08 2000-04-13 Karagoezian Hampar L Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide
JP4727816B2 (ja) * 1998-10-08 2011-07-20 エル. カラジョージアン、ハンパー 亜塩素酸塩と過酸化水素とを含有する共同作用抗菌性皮膚科・眼科製剤
US6057289A (en) * 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
US20040219219A1 (en) * 2000-07-14 2004-11-04 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
BR0112461A (pt) * 2000-07-14 2003-07-22 Allergan Inc Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
US20040214829A1 (en) * 2000-07-14 2004-10-28 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
RU2311928C2 (ru) * 2000-07-14 2007-12-10 Аллерган Инк. Композиции, содержащие альфа-2-адренергические агонисты
US20020198209A1 (en) * 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
US7045121B2 (en) * 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
US6982079B2 (en) * 2002-04-26 2006-01-03 Allergan, Inc. Compositions for treating hyperemia
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US6635654B1 (en) * 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
US7087190B2 (en) * 2003-03-20 2006-08-08 Ecolab Inc. Composition for the production of chlorine dioxide using non-iodo interhalides or polyhalides and methods of making and using the same
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods

Also Published As

Publication number Publication date
JP2006521362A (ja) 2006-09-21
CA2520521A1 (en) 2004-10-14
CN1794973A (zh) 2006-06-28
WO2004087098A2 (en) 2004-10-14
WO2004087098A3 (en) 2005-06-02
US20040191332A1 (en) 2004-09-30
EP1605912A2 (en) 2005-12-21
AU2004226466B2 (en) 2009-01-22
NZ542727A (en) 2008-09-26
CA2520521C (en) 2013-05-14
AU2004226466A1 (en) 2004-10-14
CN100528139C (zh) 2009-08-19

Similar Documents

Publication Publication Date Title
BRPI0408827A (pt) composições oftálmicas preservadas
BRPI0609393B8 (pt) usos de um composto 11-desóxi-prostaglandina
BRPI0414908A (pt) compostos de benzazóis substituìdos, composições e métodos de inibição da atividade raf quinase em um humano ou animal
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0513491A (pt) composições inseticidas com base em inseticidas e saffeners selecionados
BR112015023922A2 (pt) composição farmacêutica compreendendo um ativador de ampk e um agente serotonérgico e métodos de uso destes
BRPI0516082A (pt) poligalactomananos catiÈnicos de alto ds para produtos de cuidado com a pele
BRPI0608840B8 (pt) composição farmacêutica compreendendo uma difenil uréia substituída por ômega-carboxiarila, e seu processo de preparação
BRPI0509172A (pt) pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento
BRPI0411016A (pt) composições antisépticas, processos e sistemas
BRPI0611717A2 (pt) composto, composiÇço farmacÊutica e uso do composto
BRPI0618918B8 (pt) uso de um primeiro composto e um segundo composto para tratar uma condição de glicose sanguínea
BRPI0519698A2 (pt) misturas fungicidas, agente, processo para combater fungos nocivos fitopatogênicos, semente, e, uso dos compostos
BR0013081A (pt) Pirimidino-2,4,6-trionas inibidoras de metaloproteinases
BRPI0408902A (pt) composições de inibidores seletivos da ciclooxigenase-2 e agonistas de 5-ht 1b/1d para o tratamento e a prevenção de enxaqueca
UY31718A1 (es) Composiciones farmacéuticas acuosas que contienen complejos de borato y poliol
WO2007067519A3 (en) The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
BRPI0318278B8 (pt) Compostos de éter aminocicloexílico, composição compreendendo ditos compostos, usos dos mesmos e método para modular a atividade do canal iônico em um ambiente in vitro
WO2015023553A3 (en) Modulation of disease by administration of sulfur-containing, amino acid-specific small molecules
BRPI0519236A2 (pt) misturas fungicidas, agente, processo para combater fungos nocivos fitopatogÊnicos, semente, e, uso dos compostos
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
HK1123986A1 (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
BRPI0407529A (pt) uso de r-10-hidróxi-10,11-dihidro-carbamazepina em dor neuropática
BRPI0309768B8 (pt) composição lubrificante substancialmente anidra
BRPI0509784A (pt) misturas fungicidas para combater fungos nocivos fitopatogênicos, agente, processo para combater fungos nocivos fitopatogênicos, semente, e, uso dos compostos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/498, 33/14, 9/00; A61P 27/00

Ipc: A61K 31/498 (2011.01), A61K 33/14 (2011.01), A61K

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13, 22 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.